Skip to main content
. 2022 Jun 27;10(6):e34273. doi: 10.2196/34273

Table 1.

Clinical characteristics of patients.

Variable Control group (n=271) Intervention group (n=242) P value
Age (years), mean (SD) 50.66 (10.42) 49.01 (11.22) .09
Gender, n (%)

.64

Women 158 (58.3) 146 (60.3)

Men 113 (41.7) 96 (39.7)
Educational level, n (%)

.67

Primary school or inferior 89 (32.8) 74 (30.6)

High school 132 (48.7) 116 (47.9)

University 50 (18.5) 52 (21.5)
Personal gross income (€a/year), n (%)

.98

<8500 48 (17.7) 44 (18.2)

8500-16,999 94 (34.7) 78 (32.2)

17,000-25,499 73 (26.9) 66 (27.3)

25,500-33,999 36 (13.3) 34 (14.0)

>34,000 20 (7.4) 20 (8.3)
Country, n (%)

.26

Spain 251 (92.6) 230 (95.0)

Other countries 20 (7.4) 12 (5.0)
Number of daily cigarettes, mean (SD) 16.32 (8.04) 16.70 (7.43) .59
Previous tobacco withdrawal attempts, mean (SD) 2.37 (2.83) 2.60 (3.00) .38
Heavy Smoking Index, mean (SD) 2.65 (1.68) 2.71 (1.59) .67
Cannabis use, n (%)

.14

No 265 (97.8) 231 (95.5)

Yes 6 (2.2) 11 (4.5)
Pharmacological treatmentb, n (%) 130 (48) 119 (49.2) .63

Simple nicotine replacement treatment 10 (7.7) 13 (10.9)

Combined nicotine replacement treatment 4 (3.1) 5 (4.2)

Bupropion 24 (18.5) 21 (17.6)

Varenicline 89 (68.5) 74 (62.2)

Others 3 (2.3) 6 (5.0)

No pharmacological treatment 141 (52.0) 123 (50.8)

Baseline CO-oximetry (ppt), mean (SD) 15.51 (15.33) 14.70 (12.67) .57
EuroQol 5D-5L VASc, mean (SD) 71.8 (18.1) 69.4 (18.5) .14
EuroQol 5D-5L index, mean (SD) 0.9 (0.2) 0.9 (0.2) .11

a€1=US $1.06.

bn=130 and 119, respectively, for the IG and CG.

cVAS: visual analog scale.